Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2003 1
2004 3
2006 3
2007 4
2009 2
2010 1
2011 2
2013 1
2014 1
2015 2
2016 3
2017 2
2018 3
2019 7
2020 13
2021 9
2022 7
2023 14
2024 11
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2.
Indrigo M, Morella I, Orellana D, d'Isa R, Papale A, Parra R, Gurgone A, Lecca D, Cavaccini A, Tigaret CM, Cagnotto A, Jones K, Brooks S, Ratto GM, Allen ND, Lelos MJ, Middei S, Giustetto M, Carta AR, Tonini R, Salmona M, Hall J, Thomas K, Brambilla R, Fasano S. Indrigo M, et al. Among authors: d isa r. EMBO Mol Med. 2023 Nov 8;15(11):e15984. doi: 10.15252/emmm.202215984. Epub 2023 Oct 4. EMBO Mol Med. 2023. PMID: 37792911 Free PMC article.
The Emergency Medical Team Initiative in the Western Pacific Region.
Mamea N, Fatupaito AG, Samad MABA; Mahmood,b; Isa RBDM, Uherbelau G, Muña E, Abdullah S, Mustaffa M. Mamea N, et al. Among authors: isa rbdm. Western Pac Surveill Response J. 2024 Oct 8;14(6):1-4. doi: 10.5365/wpsar.2023.14.6.1161. eCollection 2023. Western Pac Surveill Response J. 2024. PMID: 39416873 Free PMC article. No abstract available.
Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study.
Fujino T, Okamoto H, Nishiyama D, Hayata H, Sasaki N, Kobayashi T, Maekura C, Kuwahara-Ota S, Takimoto-Shimomura T, Shimura K, Kawaji-Kanayama Y, Inoue Y, Chinen S, Isa R, Tsukamoto T, Mizutani S, Shimura Y, Kaneko H, Nakao M, Fuchida S, Takahashi R, Uchiyama H, Uoshima N, Kuroda J; Kyoto Clinical Hematology Study Group. Fujino T, et al. Among authors: isa r. Leuk Lymphoma. 2025 Aug;66(8):1425-1436. doi: 10.1080/10428194.2025.2483390. Epub 2025 Mar 25. Leuk Lymphoma. 2025. PMID: 40134133
87 results